|  | Immunostaining Results No. patients (%) |  | |
---|---|---|---|---|
Clinical Classification | Total | Capg (-) | Capg (+) | P Valuea |
Age at surgery (years) | Â | Â | Â | Â |
   < 60 | 30 | 15 (50) | 15 (50) |  |
   60 =<, < 70 | 22 | 11 (50) | 11 (50) | 0.920408 |
   70 =< | 27 | 12 (44) | 15 (56) |  |
Gender | Â | Â | Â | Â |
   Male | 53 | 23 (43) | 30 (57) | 0.337982 |
   Female | 26 | 15 (58) | 11 (42) |  |
T-primary tumour | Â | Â | Â | Â |
   T1 | 4 | 4 (100) | 0 (0) |  |
   T2 | 25 | 16 (64) | 9 (36) | 0.0140021 |
   T3 | 24 | 10 (42) | 14 (58) |  |
   T4 | 26 | 8 (31) | 18 (69) |  |
N-regional lymph node | Â | Â | Â | Â |
   N (-) | 50 | 27 (54) | 23 (46) | 0.242807 |
   N (+) | 29 | 11 (38) | 18 (62) |  |
Stage | Â | Â | Â | Â |
   I | 4 | 4 (100) | 0 (0) |  |
   II | 15 | 10 (67) | 5 (33) | 0.0191771 |
   III | 19 | 10 (53) | 9 (47) |  |
   IV | 41 | 14 (34) | 27 (66) |  |
Histopathologic type | Â | Â | Â | Â |
   Well differentiated | 46 | 23 (50) | 23 (50) |  |
   Moderately differentiated | 28 | 12 (43) | 16 (57) | 0.714701 |
   Poorly differentiated | 5 | 3 (60) | 2 (40) |  |
Tumour site | Â | Â | Â | Â |
   Tongue | 34 | 20 (59) | 14 (41) |  |
   Gingiva | 26 | 9 (35) | 17 (65) | 0.110879 |
   Oral floor | 8 | 5 (63) | 3 (37) |  |
   Buccal mucosa | 6 | 1 (17) | 5 (83) |  |
   Oropharynx | 4 | 3 (75) | 1 (25) |  |
   Lip | 1 | 0 (0) | 1 (100) |  |
Leukoplakia | 28 | 10 (36) | 18 (64) | Â |